サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：治療用呼吸器デバイスの世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合市場シェアと予測（2022年～2030年）
市場調査レポート
商品コード
1132583

治療用呼吸器デバイスの世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合市場シェアと予測（2022年～2030年）

Therapeutic Respiratory Devices Market Size By Product, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 330 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
治療用呼吸器デバイスの世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合市場シェアと予測（2022年～2030年）
出版日: 2022年10月06日
発行: Global Market Insights Inc.
ページ情報: 英文 330 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の治療用呼吸器デバイス市場は、2030年までに大幅な成長を記録すると予測されています。

業界の拡大は、免疫力の低下により呼吸器の問題を抱えやすい高齢者人口の増加に起因する可能性があります。

当レポートでは、世界の治療用呼吸器デバイス市場について調査分析し、業界の考察、セグメント分析、地域分析、競合情勢などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 治療用呼吸器デバイス業界の考察

  • 業界セグメンテーション
  • 業界情勢（2017年～2030年）
  • 業界の影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 製品別
    • 用途別
    • 最終用途別
  • 技術情勢
  • 規制情勢
    • 米国
    • 欧州
  • COVID-19の影響の分析
  • ポーターのファイブフォース分析
  • 競合情勢（2021年）
    • 企業マトリックス分析（2021年）
  • PESTLE分析

第4章 治療用呼吸器デバイス市場：製品別

  • 主なセグメントの動向
  • 気道陽圧（PAP）デバイス
    • 市場規模：地域別（2017年～2030年）
    • 持続的気道陽圧（CPAP）デバイス
    • 自動滴定気道陽圧（APAP）デバイス
    • バイレベル気道陽圧（BiPAP）デバイス
  • 酸素濃縮器
    • 市場規模：地域別（2017年～2030年）
    • 固定式酸素濃縮器
    • 可搬式酸素濃縮器
  • 人工呼吸器
    • 市場規模：地域別（2017年～2030年）
    • 成人用人工呼吸器
    • 新生児用人工呼吸器
  • 吸入器
    • 市場規模：地域別（2017年～2030年）
    • 定量噴霧式吸入器（MDI）
    • ドライパウダー吸入器（DPI）
    • ソフトミスト吸入器（SMI）
  • ネブライザー
    • 市場規模：地域別（2017年～2030年）
    • コンプレッサー式ネブライザー
    • ピストン式ハンドヘルドネブライザー
    • 超音波式ネブライザー
  • 加湿器
    • 市場規模：地域別（2017年～2030年）
    • 加温加湿器
    • パスオーバー型加湿器
    • 一体型加湿器
    • ビルトイン加湿器
    • スタンドアロン加湿器
  • その他

第5章 治療用呼吸器デバイス市場：用途別

  • 主なセグメントの動向
  • COPD
  • 閉塞性睡眠時無呼吸
  • 喘息
  • 呼吸窮迫症候群
  • 嚢胞性線維症
  • その他

第6章 治療用呼吸器デバイス市場：最終用途別

  • 主なセグメントの動向
  • 病院
  • 在宅ケア環境
  • 救急センター

第7章 治療用呼吸器デバイス市場：地域別

  • 主な地域の動向
  • 北米
    • 市場規模：国別（2017年～2030年）
    • 市場規模：製品別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 米国
    • カナダ
  • 欧州
    • 市場規模：国別（2017年～2030年）
    • 市場規模：製品別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場規模：国別（2017年～2030年）
    • 市場規模：製品別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • 市場規模：国別（2017年～2030年）
    • 市場規模：製品別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 市場規模：国別（2017年～2030年）
    • 市場規模：製品別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 企業プロファイル

  • 競合ダッシュボード（2021年）
  • Breas Medical AB
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Hamilton Medical
  • Hill-Rom Services Inc. (Baxter)
  • ICU Medical, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • VYAIRE MEDICAL, INC.
目次
Product Code: 696

The global therapeutic respiratory devices market is anticipated to register considerable growth through 2030. The industry expansion can be attributed to the rising elderly population which is prone to respiratory problems due to weakened immune systems. To that end, the instances of respiratory-related infections have also risen, leading to lung cancer, COPD, and asthma. The high rate of respiratory deaths is likely to drive product sales in the projected timeline. Also, the availability of advanced medical devices to minimize the severity of every person's medical condition will foster market growth.

The high costs associated with the treatment of respiratory diseases may be a key factor hindering the industry expansion. As per a study, asthma results in approximately 500,000 deaths annually and over 1,300 deaths daily. Rising caseloads of respiratory diseases and increased intensity of illness have raised treatment costs. Eventually, it increases the burden on healthcare units due to direct and indirect expenses.

Based on product, the industry is segmented into positive airway pressure (PAP) devices, oxygen concentrators, ventilators, inhalers, humidifiers, and nebulizers. The ventilators segment registered over USD 4 billion in 2021, owing to technological advancements in product design and the surge in the geriatric population. Additionally, improved capabilities of ventilation technologies for lung injury prevention and fewer treatment times are likely to foster the growth of the segment.

On the basis of application, the industry is classified into COPD, asthma, obstructive sleep apnea, cystic fibrosis, and respiratory distress syndrome. The asthma segment held over 28% market share in 2021, owing to the introduction of advanced medications including inhalers and nebulizers. According to the data from the Asthma and Allergy Foundation of America, nearly 25 million people are susceptible to asthma in the U.S., which is equivalent to 1 in 13 people. Additionally, the average mortality from asthma is 11 in the U.S. daily. In 2020, 4,145 patients died of asthma, which increases the need for advanced asthma medications.

Based on end-use, the industry is categorized into hospitals, homecare settings, and emergency centers. The industry size from the homecare settings segment is flourishing at a considerable rate, owing to the adoption of improved treatment procedures that require minimal intervention from doctors. In addition, the increased psychological comfort and favorable environment facilitate the patient.

On the regional front, the industry is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Latin America is expected to grow at over 4% CAGR, owing to the increased instances of respiratory problems in the region. Additionally, the adoption of the latest treatment modules for treating such ailments is likely to foster product sales in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Therapeutic respiratory devices industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Therapeutic Respiratory Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of respiratory diseases in developing countries
      • 3.3.1.2 Increasing geriatric population globally
      • 3.3.1.3 Technological innovation in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Lack of patient compliance
      • 3.3.2.2 Cost burden of respiratory diseases
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 Technology landscape
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 COVID- 19 impact analysis
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
    • 3.9.1 Company matrix analysis, 2021
  • 3.10 PESTLE analysis

Chapter 4 Therapeutic Respiratory Devices Market, By Product

  • 4.1 Key segment trends
  • 4.2 Positive Airway Pressure (PAP) devices
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 Continuous positive airway pressure (CPAP) devices
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Auto-titrating positive airway pressure (APAP) devices
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.4 Bi-level positive airway pressure (BiPAP) devices
      • 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Oxygen concentrators
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.2 Fixed oxygen concentrators
      • 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.3 Portable oxygen concentrators
      • 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Ventilators
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.2 Adult ventilators
      • 4.4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.3 Neonatal ventilators
      • 4.4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.5 Inhalers
    • 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.2 Metered dose inhaler (MDI)
      • 4.5.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.3 Dry powder inhaler (DPI)
      • 4.5.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.4 Soft mist inhaler (SMI)
      • 4.5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.6 Nebulizers
    • 4.6.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.2 Compressor-based nebulizers
      • 4.6.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.3 Piston-based hand-held nebulizers
      • 4.6.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.4 Ultrasonic nebulizers
      • 4.6.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.7 Humidifiers
    • 4.7.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.2 Heated humidifiers
      • 4.7.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.3 Passover humidifiers
      • 4.7.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.4 Integrated humidifiers
      • 4.7.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.5 Built-in humidifiers
      • 4.7.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.6 Standalone humidifiers
      • 4.7.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Therapeutic Respiratory Devices Market, By Application

  • 5.1 Key segment trends
  • 5.2 COPD
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Obstructive sleep apnea
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Asthma
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Respiratory distress syndrome
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Cystic fibrosis
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Therapeutic Respiratory Devices Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Homecare settings
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Emergency centers
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Therapeutic Respiratory Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.2.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.2.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.2.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.2.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.2.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.2.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.3.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.3.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.3.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.3.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.3.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.3.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.4.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.4.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.4.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.4.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.4.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.4.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.5.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.5.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.5.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.5.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.5.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.5.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.6.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.6.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.6.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.6.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.6.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.6.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2021
  • 8.2 Breas Medical AB
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 Swot analysis
  • 8.3 Dragerwerk AG & Co. KGaA
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 Swot analysis
  • 8.4 Fisher & Paykel Healthcare Limited
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 Swot analysis
  • 8.5 GE Healthcare
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 Swot analysis
  • 8.6 Hamilton Medical
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 Swot analysis
  • 8.7 Hill-Rom Services Inc. (Baxter)
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 Swot analysis
  • 8.8 ICU Medical, Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 Swot analysis
  • 8.9 Invacare Corporation
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 Swot analysis
  • 8.10 Koninklijke Philips N.V.
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 Swot analysis
  • 8.11 Medtronic
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 Swot analysis
  • 8.12 ResMed
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 Swot analysis
  • 8.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 Swot analysis
  • 8.14 VYAIRE MEDICAL, INC.
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 Swot analysis